Ethos Technologies LIFE
NASDAQ LIFE
$38.78 -0.94 (-2.37%)
As of: Sep 10, 2026 · 3:59 PM EDT

Ethos Technologies (LIFE) Capital Expenditures (2025 - 2026)

Ethos Technologies (LIFE) posted Capital Expenditures of $325000.0 for Q2 2026, down 7.93% on a QoQ basis from $353000.0 in Q1 2026, and up 8.33% year-over-year from $300000.0 in Q2 2025.

Analysis

Ethos Technologies (LIFE) Capital Expenditures (2025 - 2026) Analysis & Trends

Ethos Technologies has reported Capital Expenditures for 2 years, with the latest figure at $325000.0 in Q2 2026.

  • On a quarterly basis, Capital Expenditures rose 8.33% year-over-year to $325000.0 in Q2 2026; TTM through Jun 2026 was $1.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.5 million, up 92.14% from the prior year.
  • Capital Expenditures was $325000.0 for Q2 2026 at Ethos Technologies, down from $353000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $353000.0 in Q1 2026, with the low at $278000.0 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Hinge Health 6.99 Bn 6.60 Bn 183.95 Mn 1.73 Mn
2 Hims & Hers Health 6.38 Bn 5.54 Bn 480.80 Mn 25.93 Mn
3 Ethos Technologies 2.47 Bn 2.30 Bn 185.54 Mn 325,000.00
4 Omada Health 1.28 Bn 1.06 Bn 63.79 Mn 1.52 Mn
5 Teladoc Health 1.11 Bn 330.82 Mn 416.09 Mn 27.99 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn 3.13 Mn
7 Akso Health 208.18 Mn 208.01 Mn - -
8 LifeMD 145.04 Mn 145.04 Mn - -
9 eHealth 29.43 Mn -71.61 Mn - 2.20 Mn
10 Mangoceuticals 6.82 Mn 6.58 Mn 44,215.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 325,000.00
Mar 31, 2026 353,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 278,000.00